Literature DB >> 16765655

Performance comparison of protein A affinity resins for the purification of monoclonal antibodies.

K Swinnen1, A Krul, I Van Goidsenhoven, N Van Tichelt, A Roosen, K Van Houdt.   

Abstract

During the selection of protein A affinity resin for the purification of monoclonal antibodies, dynamic binding capacity (Q(dyn10%)), volumetric production rate (Pr(vol)) and 'process robustness' are essential parameters to be evaluated. In this article, empirical mathematical models describe these parameters as a function of antibody concentration in load (C0), load flow rate (u(load)) and bed height (L). These models allow us to select optimal process conditions for each of the evaluated protein A affinity resins. C0, u(load) and L largely affect dynamic binding capacity (Q(dyn10%)) and volumetric production rate (Pr(vol)). Maximum Q(dyn10%) is generally obtained at high C0 and at low u(load). Maximum Pr(vol) is obtained at high C0 and at lowest L, run at high u(load). All evaluated resins have a relatively high robustness against variations in C0. |DeltaQ(dyn10%)/deltaC0| ranges from 0.0 to 7.8. It is clear that Q(dyn10%), Pr(vol) and 'process robustness' cannot be maximized all at the same time. Furthermore, some other aspects like IgG recovery, protein A leaching, easiness to pack, easiness to clean, number of re-uses and cost of production might be important to be taken into the equation. Certain evaluation parameters may be more important than others, depending on the specific situation. Therefore, a case-by-case evaluation is recommended.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765655     DOI: 10.1016/j.jchromb.2006.04.050

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Evaluation of a novel methacrylate-based Protein A resin for the purification of immunoglobulins and Fc-fusion proteins.

Authors:  Tyler R McCaw; Edward K Koepf; Lynn Conley
Journal:  Biotechnol Prog       Date:  2014-07-24

2.  An integrated and continuous downstream process for microbial virus-like particle vaccine biomanufacture.

Authors:  Lukas Gerstweiler; Jagan Billakanti; Jingxiu Bi; Anton P J Middelberg
Journal:  Biotechnol Bioeng       Date:  2022-05-10       Impact factor: 4.395

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.